P. Liebson

发表

Treatment of Mild Hypertension Study: Final Results

C. Lewis, J. Cutler, R. Prineas, 1993 .

2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

A. Jaffe, M. Sabatine, H. Jneid, 2014, Circulation.

A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

A. Jaffe, M. Sabatine, H. Jneid, 2015 .

The non-Q wave myocardial infarction revisited: 10 years later.

L. Klein, P. Liebson, Lloyd W. Klein, 1997, Progress in cardiovascular diseases.

Intravascular ultrasound in coronary atherosclerosis: a new approach to clinical assessment.

L. Klein, P. Liebson, P R Liebson, 1992, American heart journal.

Cardiovascular risk in special populations IV: Congenital heart defects.

P. Liebson, 2010, Preventive cardiology.

Determination of Cardiac Output in Critically III Patients by Dual Beam Doppler Echocardiography

R. Bone, R. Balk, J. Messer, 1989, Journal of the American College of Cardiology.

Effect of left atrial size on recurrence of atrial fibrillation after electrical cardioversion: atrial dimension versus volume.

J. Soble, A. Volgman, A. Neumann, 1996, American journal of cardiac imaging.

ASCOT-Blood Pressure Trial (ASCOT-BPLA) and HOPE-TOO.

P. Liebson, 2006, Preventive cardiology.

Jupiter and accomplish.

P. Liebson, 2009, Preventive cardiology.

CHARISMA and TROPHY.

P. Liebson, 2006, Preventive cardiology.

Evaluation of Diastolic Function: How Practical Is It?

P. Liebson, R. Doukky, Melissa J. Tracy, 2020 .

Hormone Therapy and Selective Estrogen Receptor Modulators for Prevention of Coronary Heart Disease in Postmenopausal Women: Estrogen Replacement from the Cardiologist's Perspective

L. Klein, P. Liebson, Sara Mobasseri, 2004, Cardiology in review.

AVID and COMET.

P. Liebson, 2003, Preventive cardiology.

Substudies of ALLHAT and Heart Protection Study.

P. Liebson, 2005, Preventive cardiology.

Women's health study (aspirin) and TNT.

P. Liebson, 2005, Preventive cardiology.

CARDS and A to Z.

P. Liebson, 2005, Preventive cardiology.

LIFE and ARBITER.

P. Liebson, 2003, Preventive cardiology.

Chronobiology of acute myocardial infarction: cardiac arrhythmia suppression trial (CAST) experience.

R. Peters, P. Liebson, M. Brooks, 1996, The American journal of cardiology.

Diabetes Control and Cardiovascular Risk: ACCORD, ADVANCE, AVOID, and SANDS.

P. Liebson, 2008, Preventive cardiology.

CHICAGO and RIO-Diabetes.

P. Liebson, 2007, Preventive cardiology.

Cardiovascular disease in special populations III: stroke.

P. Liebson, 2010, Preventive cardiology.

Cost‐Effectiveness of Echocardiography and Electrocardiography for Detection of Left Ventricular Hypertrophy in Patients with Systemic Hypertension

J. Laragh, P. Kligfield, R. Devereux, 1987, Hypertension.

Left Ventricular Hypertrophy in Hypertension

P. Liebson, 2002, Heart Drug.

Left ventricular hypertrophy

P. Liebson, 1999, Current treatment options in cardiovascular medicine.

Echocardiography in multicenter clinical trials: experience from the Treatment of Mild Hypertension Study.

R. Prineas, G. Grandits, P. Liebson, 1994, Controlled clinical trials.

Hemodynamic Correlates of the Third Heart Sound During the Evolution of Chronic Heart Failure

J. Cutler, R. Prineas, J. Stamler, 1993, Circulation.

Population-derived comparisons of ambulatory and office blood pressures. Implications for the determination of usual blood pressure and the concept of white coat hypertension.

J. Neaton, R. Grimm, K. Ensrud, 1992, Archives of internal medicine.

Development and Validation of Risk Prediction Models for Cardiovascular Events in Black Adults: The Jackson Heart Study Cohort.

M. Pencina, R. Vasan, A. Folsom, 2016, JAMA cardiology.

Left ventricular structure and systolic function in African Americans: the Atherosclerosis Risk in Communities (ARIC) study.

E. Benjamin, R. Hutchinson, D. Arnett, 2004, Ethnicity & disease.

Hypertension research. Echocardiography in the measurement of left ventricular wall mass.

R. Devereux, M. Horan, P. Liebson, 1987, Hypertension.

Echocardiography in Hypertension: A Review I. Left Ventricular Wall Mass, Standardization, and Ventricular Function

D. Savage, P. Liebson, 1986 .

Echocardiography: left ventricular hypertrophy and atherosclerosis

P. Liebson, 2008 .

Hypertension — Diagnosis And Treatment

H. Black, P. Liebson, 1999 .

The Relation of Diabetes, Impaired Fasting Blood Glucose, and Insulin Resistance to Left Ventricular Structure and Function in African Americans

R. Garrison, G. Howard, M. Sims, 2011, Diabetes Care.

ACTIVE A and AURORA.

P. Liebson, 2009, Preventive cardiology.

ILLUSTRATE and METEOR.

P. Liebson, 2007, Preventive cardiology.

ALLHAT and AFFIRM.

P. Liebson, 2003, Preventive cardiology.

Comparison of cine magnetic resonance imaging and Doppler echocardiography for evaluation of left ventricular diastolic function.

James Ze Wang, D. Turner, P. Liebson, 1997, The American journal of cardiology.

VALUE and WALNUT

P. Liebson, 2004 .

Echocardiographic Studies of Regression of Left Ventricular Hypertrophy in Hypertension

F. Fouad-Tarazi, P. Liebson, 1987, Hypertension.

Relation of left ventricular geometry and function to systemic hemodynamics in hypertension: The LIFE Study

R. Devereux, J. Bella, V. Palmieri, 2001, Journal of hypertension.

Distribution and determinants of Doppler-derived diastolic flow indices in African Americans: the Jackson Heart Study (JHS).

R. Garrison, G. Howard, E. Fox, 2009, American heart journal.

Clinical studies of drug reversal of hypertensive left ventricular hypertrophy.

P. Liebson, 1990, American journal of hypertension.

ENHANCE and ONTARGET.

P. Liebson, 2008, Preventive cardiology.

α-Blockade and thiazide treatment of hypertension A double-blind randomized trial comparing doxazosin and hydrochlorothiazide

R. Grimm, J. Flack, J. Schoenberger, 1996 .

Circadian pattern of arrhythmic death in patients receiving encainide, flecainide or moricizine in the Cardiac Arrhythmia Suppression Trial (CAST).

R. Peters, L. Mitchell, H. Greene, 1994, Journal of the American College of Cardiology.

New Insights into Diastolic Dysfunction as the Cause of Acute Left-Sided Heart Failure Associated With Systemic Hypertension and/or Coronary Artery Disease

R. Devereux, T. Pickering, J. Bella, 2002 .

Acute myocardial infarction diagnosed by myoglobinuria.

H. Kessler, P. Liebson, E. C. Adams, 1975, Archives of internal medicine.

Assessment of Left Ventricular Function in Secundum Atrial Septal Defect: Evaluation by Determination of Volume, Pressure, and External Systolic Time Indices

K. Ehlers, A. Levin, P. Liebson, 1975, Pediatric Research.

The thiazolidinedione controversy in cardiovascular risk.

P. Liebson, 2010, Preventive cardiology.

Obesity and bariatric surgery: two studies.

P. Liebson, 2008, Preventive cardiology.

Recommendations Concerning Use of Echocardiography in Hypertension and General Population Research

R. Devereux, M. Horan, P. Liebson, 1987, Hypertension.

Effects of dilevalol, metoprolol and atenolol on left ventricular mass and function in nonelderly and elderly hypertensive patients.

S. Glasser, W. Frishman, J. Strom, 1989, The American journal of cardiology.

Heart Failure With a Normal Ejection Fraction: Is Measurement of Diastolic Function Necessary to Make the Diagnosis of Diastolic Heart Failure?

J. Carroll, G. Aurigemma, W. Gaasch, 2001, Circulation.

Identification of a secondary peak in myocardial infarction onset 11 to 12 hours after awakening: the Cardiac Arrhythmia Suppression Trial (CAST) experience.

R. Peters, Y. Pawitan, M. Proschan, 1993, Journal of the American College of Cardiology.

Alpha-blockade and thiazide treatment of hypertension. A double-blind randomized trail comparing doxazosin and hydrochlorothiazide.

R. Grimm, J. Flack, J. Schoenberger, 1996, American journal of hypertension.

Echocardiography in Hypertension: A Review

D. Savage, P. Liebson, 1987 .

VALIANT and EUROPA.

P. Liebson, 2004, Preventive cardiology.

Left Ventricular Hypertrophy in Hypertension

P. Liebson, 2002, Heart Drug.

The conduction system in mitral valve prolapse syndrome with sudden death.

K. Rosen, H. Loeb, S. Bharati, 1981, American heart journal.

Semiautomatic evaluation of left ventricular diastolic function with cine magnetic resonance imaging.

James Ze Wang, D. Turner, F. Hoff, 1994, Academic radiology.

ASAP and ANTIBIO.

P. Liebson, 2003, Preventive cardiology.

Coronary angiography in patients with established coronary artery disease: how much does the angiogram help in assessing changes in symptoms?

L. Klein, P. Liebson, Lloyd W. Klein, 1994, Catheterization and cardiovascular diagnosis.

Electrocardiographic abnormalities in mitral valve prolapse.

J. Parrillo, P. Liebson, E. Uretz, 1992, The American journal of cardiology.

Echocardiography in Electrophysiologic Studies: A Review

P. Liebson, 1984 .

Effect of contrast enhancement on measurement of carotid artery intimal medial thickness.

S. Feinstein, P. Liebson, P. Meyer, 2002, Vascular medicine.

The use of noninvasive methods in the evaluation of left ventricular performance in coronary artery disease. I. Relation of systolic time intervals to angiographic assessment of coronary artery disease severity.

P. Liebson, J. Teran, M. Lurie, 1975, American heart journal.

Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional-hygienic therapy in the Treatment of Mild Hypertension Study (TOMHS).

R. Prineas, J. Neaton, J. Stamler, 1995, Circulation.

Regression of left ventricular hypertrophy.

R. Grimm, G. Grandits, P. Liebson, 1996, JAMA.

Use of noninvasive methods in evaluation of left ventricular performance in coronary artery disease. II: Change in systolic time intervals after coronary artery bypass in patients with stable angina.

P. Liebson, R. Meng, C. Hollander, 1976, British heart journal.

Diet, lifestyle, and hypertension and mediterranean diet and risk of dementia.

P. Liebson, 2010, Preventive cardiology.

Urinary albumin and N-acetyl-β-D-glucosaminidase excretions in mild hypertension

R. Grimm, S. Mascioli, J. Flack, 1994 .

Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population : the LIFE study.

R. Devereux, J. Bella, M. Roman, 2000, Hypertension.

Relation between electrocardiography and echocardiography for left ventricular mass in mild systemic hypertension (results from Treatment of Mild Hypertension Study).

R. Prineas, P. Rautaharju, P. Hannan, 1995, The American journal of cardiology.

Prevention of coronary heart disease. Part I. Primary prevention.

E. Amsterdam, P. Liebson, Ezra A. Amsterdam, 1999, Disease-a-month : DM.

Relationships of quality-of-life measures to long-term lifestyle and drug treatment in the Treatment of Mild Hypertension Study.

A. Stewart, J. Cutler, R. Mcdonald, 1997, Archives of internal medicine.

2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

A. Jaffe, M. Sabatine, H. Jneid, 2014, Circulation.

Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial.

H L Greene, R. Peters, L. Mitchell, 1991, The New England journal of medicine.

Cardiac performance during pregnancy: serial evaluation using external systolic time intervals.

M. Evans, P. Liebson, P R Liebson, 1975, American journal of obstetrics and gynecology.

Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS)

C. Lewis, R. Mcdonald, R. Prineas, 1997, Hypertension.

Unstable angina and non-Q wave myocardial infarction: does the clinical diagnosis have therapeutic implications?

L. Klein, J. Parrillo, J. Calvin, 1999, Journal of the American College of Cardiology.

Chapter 15 – Assessment of Hypertensive Target Organ Damage

P. Gorelick, J. Izzo, J. Reidy, 2007 .

Palpitations in a Patient With Morbid Obesity

P. Liebson, A. Susmano, T. Quinn, 1985 .

Long-Term Effects on Sexual Function of Five Antihypertensive Drugs and Nutritional Hygienic Treatment in Hypertensive Men and Women: Treatment of Mild Hypertension Study (TOMHS)

C. Lewis, R. Mcdonald, R. Prineas, 1998 .

Stem‐Cell Angiogenesis and Regeneration of the Heart: Review of a Saga of 2 Decades

P. Liebson, 2015, Clinical cardiology.

Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET): implications for reduced cardiovascular risk.

E. Amsterdam, P. Liebson, 2009, Preventive cardiology.

Prevention of coronary heart disease. Part II. Secondary prevention, detection of subclinical disease, and emerging risk factors.

E. Amsterdam, P. Liebson, 2000, Disease-a-month : DM.

Risk stratification post-myocardial infarction: is early coronary angiography the more effective strategy?

L. Klein, J. Parrillo, J. Forrester, 2002, Progress in cardiovascular diseases.

PEACE and CAMELOT.

P. Liebson, 2005, Preventive cardiology.

Calcium channel blockers in the spectrum of antihypertensive agents

P. Liebson, 2006, Expert opinion on pharmacotherapy.

ILLUMINATE-Part 2 and CORONA.

P. Liebson, 2008, Preventive cardiology.

Comparison of the prognostic value of left ventricular hypertrophy in African-American men versus women.

E. Benjamin, D. Arnett, E. Núñez, 2004, The American journal of cardiology.

Optimal antihypertensive therapy for prevention and treatment of left ventricular hypertrophy

P. Liebson, R. Serry, 2000, Current hypertension reports.

Optimal Threshold Value for Left Ventricular Hypertrophy in Blacks: The Atherosclerosis Risk in Communities Study

E. Benjamin, D. Arnett, E. Núñez, 2005, Hypertension.

Diabetes, gender, and left ventricular structure in African-Americans: the atherosclerosis risk in communities study

E. Benjamin, B. Duncan, T. Manolio, 2006, Cardiovascular ultrasound.

One-Year Study of Felodipine or Placebo for Stage 1 Isolated Systolic Hypertension

H. Black, W. Frishman, W. Elliott, 2001, Hypertension.

Mortality following ventricular arrhythmia suppression by encainide, flecainide, and moricizine after myocardial infarction. The original design concept of the Cardiac Arrhythmia Suppression Trial (CAST).

W. Rogers, D. Wyse, A. Hallstrom, 1993, JAMA.

Review of Cardiovascular Disease in Women: Awareness, Prevention, and Psychosocial Characteristics

L. Klein, P. Liebson, Sara Mobasseri, 2003, Heart Drug.

Cardiovascular risk in special populations II: hypertension.

P. Liebson, 2009, Preventive cardiology.

Transesophageal echocardiography in critically ill patients: what is the intensivist's role?

P. Liebson, 2002, Critical care medicine.

ARBITER-6 HALTS and lipid concentrations and heart failure incidence: Framingham Heart Study.

P. Liebson, 2010, Preventive cardiology.

Comparison of m-mode echocardiographic left ventricular mass measured using digital and strip chart readings: The Atherosclerosis Risk in Communities (ARIC) study

E. Benjamin, R. Hutchinson, D. Arnett, 2003, Cardiovascular ultrasound.

Role of surrogate markers in assessing patients with diabetes mellitus and the metabolic syndrome and in evaluating lipid-lowering therapy.

S. Feinstein, P. Liebson, P. Meyer, 2004, The American journal of cardiology.

Clinical Correlates and Prognostic Significance of Change in Standardized Left Ventricular Mass in a Community‐Based Cohort of African Americans

R. Vasan, S. Musani, E. Fox, 2015, Journal of the American Heart Association.

Women's Health Initiative (WHI) Dietary Trial and Norwegian Vitamin Trial (NORVIT).

P. Liebson, 2006, Preventive cardiology.

Counterpulsation and dobutamine. Their use in treatment of cardiogenic shock due to right ventricular infarct.

P. Liebson, M. Iqbal, 1981, Archives of internal medicine.

Is the echocardiogram an appropriate ECG validity standard for the detection and change in left ventricular size?

R S Crow, P. Hannan, R. Crow, 1996, Journal of electrocardiology.

Relations Between Subclinical Disease Markers and Type 2 Diabetes, Metabolic Syndrome, and Incident Cardiovascular Disease: The Jackson Heart Study

R. Vasan, S. Musani, M. Sims, 2015, Diabetes Care.

DREAM and SPARCL.

P. Liebson, 2007, Preventive cardiology.

Effect of contrast enhancement on measurement of carotid artery intimal medial thickness

S. Feinstein, P. Liebson, P. Meyer, 2004 .

Visualization of an anomalous left main coronary artery with two-dimensional echocardiography.

J. Messer, P. Liebson, J. Plehn, 1988, American heart journal.

Ventricular Failure-Reply

P. Liebson, M. Iqbal, 1981 .

Smoking cessation and arrhythmic death: The CAST experience

R. Peters, L. Wilhelmsen, P. Liebson, 1995 .

Smoking cessation and arrhythmic death: the CAST experience. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators.

R. Peters, L. Wilhelmsen, P. Liebson, 1995, Journal of the American College of Cardiology.

Cardiovascular risk in special populations: overview.

P. Liebson, 2009, Preventive cardiology.

Comparison of auscultation with two‐dimensional and doppler echocardiography in patients with suspected mitral valve prolapse

P. Liebson, J. T. Barron, D. L. Manrose, 1988, Clinical cardiology.

Philosophy of science and medicine seriesâ€”IV: Alexandrian period

P. Liebson, 2011 .

The rosiglitazone controversy: meta-analysis and the RECORD study.

P. Liebson, 2007, Preventive cardiology.

Circadian pattern of arrythmic death in patients receiving encainide, Flecainide or moricizine in the cardiac arrhythmia☆

R. Peters, H. Greene, R. Capone, 1994 .

Clre-i 77 .-. 1 rn 0 7 : 2 n of AM & Encai _ ' ide , FV oesainide or fdoz ! Suppression Trial ( CAST )

R. Peters, L. Mitchell, P. Liebson, 2016 .

VISP and INVEST.

P. Liebson, 2004, Preventive cardiology.

Left Ventricular Mass Indexed to Height and Prevalent MRI Cerebrovascular Disease in an African American Cohort: The Atherosclerotic Risk in Communities Study

E. Benjamin, D. Arnett, Jingzhong Ding, 2005, Stroke.

2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

R. Brindis, R. Smalling, M. Kontos, 2014, Journal of the American College of Cardiology.

Relation of circadian ventricular ectopic activity to cardiac mortality. CAST Investigators.

R. Peters, E. Rapaport, A. Gillis, 1996, The American journal of cardiology.

Echocardiographic diagnosis of mobile right atrial thrombus: early recognition and treatment.

P. Liebson, J. Plehn, T. Quinn, 1984, American heart journal.

Diabetes control and cardiovascular risk, Part II: Intensive glucose control--UKPDS follow-up.

P. Liebson, 2009, Preventive cardiology.

Prevention of coronary heart disease. Part II. Secondary prevention, detection of subclinical disease, and emerging risk factors.

E. Amsterdam, P. Liebson, 2000, Disease-a-month : DM.